Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Pfizer Inc |
U.S.A |
Pharmacia and Upjohn Company LLC | 0009-0106 | Taliglucerase alfa | 2012-05-01 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (200U/5mL) |
| 28/03/2025 | Protalix BioTherapeutics |
Israel |
Protalix Ltd | 50210-248 | Taliglucerase alfa | 2012-05-01 | 2025-12-31 | BULK INGREDIENT | INJECTION, POWDER, FOR SOLUTION (150000U/150000U) |
